Werewolf Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Werewolf Therapeutics generated cash of -$32,612,000, which is more than the previous year. Cash used in financing activities reached the amount of $58,429,000 last year. Net change in cash is therefore $25,048,000.
Cash Flow
| 2019 | -9.54M | -266K | 21.90M |
|---|---|---|---|
| 2020 | -18.62M | -560K | 93.85M |
| 2021 | -42.87M | -498K | 109.42M |
| 2022 | -40.59M | -3.61M | 15.90M |
| 2023 | -32.61M | -769K | 58.42M |
HOWL Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 130.52M | 158.83M | 92.77M | 18.10M | 6.00M |
Operating activities | |||||
Net income | -37.36M | -53.81M | -49.98M | -15.04M | -10.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.76M | 1.10M | 216K | 150K | 25K |
Stock-based compensation expense | 8.00M | 7.4M | 4.09M | 632K | 559K |
| Deferred income tax benefit | 8.00M | 7.4M | 4.09M | 632K | 559K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 5.57M | -6.92M | 0 | 0 | 0 |
Inventories | 0 | 6.92M | 0 | 0 | 0 |
Accounts payable | -4.33M | -883K | 1.00M | 388K | 116K |
Cash generated by operating activities | -32.61M | -40.59M | -42.87M | -18.62M | -9.54M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -769K | -3.61M | -498K | -560K | -266K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -769K | -3.61M | -498K | -560K | -266K |
Financing activities | |||||
Common Stock Issued | 18.32M | 15.74M | 111.6M | 94.01M | 2K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 40M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 58.42M | 15.90M | 109.42M | 93.85M | 21.90M |
Net Change In Cash | 25.04M | -28.30M | 66.05M | 74.67M | 12.10M |
Cash at end of period | 155.57M | 130.52M | 158.83M | 92.77M | 18.10M |
| Data source | Data source | Data source |